HomeREGULATORY
REGULATORY

MHLW Orders Label Revisions for Abilify, 4 Other APIs
(Jan.12.2018)

The Ministry of Health, Labor and Welfare (MHLW) on January 11 ordered label revisions for Otsuka Pharmaceutical’s antipsychotic Abilify (aripiprazole/aripiprazole hydrate) and its generic versions, and four other APIs including Lixiana (edoxaban) ...
(LOG IN FOR FULL STORY)

News Calendar